Development of a hybrid bioartificial liver

Annals of Surgery

Volumn 217, Issue 5, 1993, Pages 502-511

  Rozga, Jacek ^a   Holzman, Michael D ^b   Ro, Man Soo ^b   Griffin, Donald W ^b   Neuzil, Daniel F ^b   Giorgio, Todd ^b   Moscioni, Albert D ^a   Demetriou, Achilles A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL;

AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; DOG; EXTRACORPOREAL CIRCULATION; GLUCOSE BLOOD LEVEL; HEMOPERFUSION; HUMAN; LACTATE BLOOD LEVEL; LIVER CELL; LIVER FAILURE; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME;

ANIMAL; ARTIFICIAL ORGANS; CASE REPORT; CHARCOAL; COMPARATIVE STUDY; DOGS; EQUIPMENT DESIGN; FEMALE; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER; MALE; MIDDLE AGE; PERFUSION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027232692     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199305010-00010     Document Type: Article

References (30)

1. Pappas SC. Fulminant hepatic failure and the need for artificial liver support. Mayo Clin Proc 1988; 63:198-200.
2. Burnell JM, Runge C, Saunders FC, Thomas ED, Volwiler W. Acute hepatic failure treated by cross circulation. Arch Intern Med 1973; 132:493-498.
3. Bihari D, Hughes RD, Gimson AES. et al. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs 1983; 6:299-302.
4. Parhhoo SP, James IM, Ajdukiewicz A, et al. Extracorporeal pigliver perfusion in treatment of hepatic coma due to fulminant hepatitis. Lancet 1971; ii:659-665.
5. Abouna GM, Cook JS, Fisher LMA, et al. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgen 1972; 71:537-546.
6. Gimson AES, Mellon PJ, Braude S. Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982: ii:681-683.
7. Smith JW, Matsubara S. Horiuchi T, et al. Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation. Trans Am Soc Artif Intern Organs 1982; 28:215-219.
8. Silk DBA, Trewby PN, Chase RA, et al. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet 1977; ii:1-3.
9. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978; 19:787-793.
10. Redeker AG, Yamahiro HS. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973: ii:3-6.
11. Cooper GN, Karlson KE, Clowes GHA, Martin H, Randall HT. Total body washout and exchange: a valuable tool in acute hepatic coma and Reye's syndrome. Am J Surg 1977; 133:522-530.
12. Denti E, Luboz MP. Preparation and properties of gel-entrapped liver cell microsomes. in Williams R. Murray-Lyon IM, eds. Artificial Liver Support. Kent, UK: Pitman Medical. 1974, pp 148-152.
13. Usami M, Ohyanagi H, Nishimatsu S. et al. Therapeutic plasmapheresis for liver failure after hepatectomy. Trans Am Soc Artif Intern Organs 1989; 35:564-567.
14. Olumide F, Eliashiv A, Kralios N, Norton L, Eiseman B. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 1977; 82:599-606.
15. Yanagi K, Ookawa K, Shuichi M, Oshima N. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a Hydrogel. Trans Am Soc Artif Intern Organs 1989; 35:570-572.
16. Matsumura KN, Guevara GR, Huston H, et al. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101:99-103.
17. Saito S, Sakagami K, Orita K. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. Trans Am Soc Artif Intern Organs 1987; 33:459-462.
18. Chang T, Williams R, Mose Y. A multifaceted approach to artificial liver support. Trans Am Soc Artif Intern Organs 1983; 29:795-799.
19. Horak J, Horky J, Rabl M. Haemoperfusion through activated charcoal in dogs with fulminant liver failure. Digestion 1980; 20:22-30.
20. Berk PD, Goldberg JH. Charcoal haemoperfusion: plus Ca change, plus C'est la meme chose. Gastroenterology 1988; 94:1228-1230.
21. O'Grady JG, Gimson AES, O'Brien CJ, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94:1186-1192.
22. Wang S, Renaud G, Infante J, Catala D, Infante R. Isolation of rat hepatocytes with EDTA and their metabolic function in primary culture. In Vitro Cell Devel Biol 1985; 21:526-530.
23. Leffert H, Koch K, Moral T. Rubalcava B. Hormonal control of rat liver regeneration. Gastroenterology 1979; 76:1470-1482.
24. Demetriou AA, Whiting JF, Feldman D, et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986; 23:1190-1192.
25. Rozga J, Williams F, Ro M-S, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology in press.
26. Gimson AES, Mellon PJ, Braude S, Canalese J, Williams R. Earlier charcoal haemoperfusions in fulminant hepatic failure. Lancet 1982; ii:681-683.
27. Chang TMS. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review. Semin Liver Dis 1986; 6:148-158.
28. Arnaout WS, Moscioni AD, Barbour RL, Demetriou AA. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res 1990; 48:379-382.
29. Haas TH, Holloway CJ, Osterthuss V. Trautschold I. Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture. J Clin Chem Clin Biochem 1981; 19:283-290.
30. Gove CD, Hughes RD, Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure. BrJ Exp Pathol 1982; 63:547-561.